Skip to main content
2024 CRT Conference Main banner
Back

Late-Breaking

Late-Breaking Early Feasibility Study Clinical Trials

Late-Breaking Early Feasibility Study Clinical Trials

Sunday, March 10, 2024
3:15 PM – 4:27 PM ET

    Moderator(s)

  • Kevin Croce, MD, PhD

    Director of CTO and Complex PCI Programs
    Brigham and Women's Hospital
    Harvard Medical School
    Boston, Massachusetts, United States

    • Panel Discussant(s)

  • Ori Ben-Yehuda, MD

    Professor of Medicine
    University of California, San Diego
    La Jolla, California, United States

  • Santiago Garcia, MD

    Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
    The Christ Hospital
    Cincinnati, Ohio, United States

  • Philippe Généreux, MD

    Co-Director, Valve & Structural Heart Center
    Morristown Medical Center
    Morristown, New Jersey, United States

  • Christina Grothusen, MD

    Associate Professor
    St. Johannes-Hospital/University Hospital Schleswig-Holstein
    Dortmund, Nordrhein-Westfalen, Germany

  • Tarek Helmy, MD, FACC, MSCAI

    Chief of Cardiology and Director of Cardiac Cath Lab
    Ochsner LSU
    Shreveport, Louisiana, United States

  • Hani Jneid, MD

    Hani Jneid, MD, FACC, FAHA, FSCAI John Sealy Distinguished Centennial Chair in Cardiology Professor & Chief, Division of Cardiology Department of Internal Medicine Medical Director, Cardiovascular Service Line University of Texas Medical Branch
    University of Texas Medical Branch
    Galveston, Texas, United States

Disclosure(s):
Ori Ben-Yehuda, MD: Bioventrix, Inc: Consultant (Ongoing); Cardiovalve: Advisor (Ongoing), Consultant (Ongoing)
Philippe Généreux, MD: No financial relationships to disclose
Christina Grothusen, MD: No relationships to disclose
Hani Jneid, MD: No relationships to disclose

Presentations:

  • 3:15 PM – 3:23 PM ET
    SESAME Transcatheter Myotomy: The Emory Experience

    Speaker: Vasilis Babaliaros, MD – Emory University Hospital

  • 3:23 PM – 3:27 PM ET
    Panel Discussion
  • 3:27 PM – 3:35 PM ET
    DurAVR Biomimetic Transcatheter Heart Valve: Early Feasibility Study (EFS) Update

    Speaker: Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI – US Heart & Vascular, Tucson Medical Center

  • 3:35 PM – 3:39 PM ET
    Panel Discussion
  • 3:39 PM – 3:47 PM ET
    Transcatheter Treatment of Chronic Aortic Regurgitation with a Novel Device: Results of J-Valve Transfemoral Early Feasibility Study (JVTF EFS)

    Speaker: Santiago Garcia, MD – The Christ Hospital

  • 3:47 PM – 3:51 PM ET
    Panel Discussion
  • 3:51 PM – 3:59 PM ET
    TAVR Designs for Non-Calcific Regurgitation and Calcific Stenosis – The Laguna Tech Solution

    Speaker: Scott Lim, MD – University of Virginia

  • 3:59 PM – 4:03 PM ET
    Panel Discussion
  • 4:03 PM – 4:11 PM ET
    Three-Dimension Intracardiac (3D-ICE) vs Transesophageal (TEE) Echocardiography to Guide Transcatheter Edge-to-Edge Repair (TEER) With MitraClip: Interim Results of the 3 Dice-Clip Trial

    Speaker: Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI – Heart and Vascular Institute (HVI) at Tampa General Hospital (TGH) in Tampa, FL

  • 4:11 PM – 4:15 PM ET
    Panel Discussion
  • 4:15 PM – 4:23 PM ET
    VELAZQUEZ EPIC26 Study: ihtDEStiny® Coronary Stent

    Speaker: Armando Perez De Prado, MD. PhD – Hospital Universitario de Leon

  • 4:23 PM – 4:27 PM ET
    Panel Discussion
  • 4:27 PM ET
    Adjourn